BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8673629)

  • 21. Oxysterols in biological systems: sources, metabolism and pathophysiological relevance.
    van Reyk DM; Brown AJ; Hult'en LM; Dean RT; Jessup W
    Redox Rep; 2006; 11(6):255-62. PubMed ID: 17207307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structures of biologically active oxysterols determine their differential effects on phospholipid membranes.
    Massey JB; Pownall HJ
    Biochemistry; 2006 Sep; 45(35):10747-58. PubMed ID: 16939227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macrophage 3-hydroxy-3-methylglutaryl coenzyme a reductase activity in sitosterolemia: effects of increased cellular cholesterol and sitosterol concentrations.
    Nguyen LB; Salen G; Shefer S; Tint GS; Ruiz F
    Metabolism; 2001 Oct; 50(10):1224-9. PubMed ID: 11586498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mass spectrometric detection of cholesterol oxidation in bovine sperm.
    Brouwers JF; Boerke A; Silva PF; Garcia-Gil N; van Gestel RA; Helms JB; van de Lest CH; Gadella BM
    Biol Reprod; 2011 Jul; 85(1):128-36. PubMed ID: 21415139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blocking late cholesterol biosynthesis inhibits the growth of transplanted Morris hepatomas (7288CTC) in rats.
    Xu G; Salen G; Lea M; Tint GS; Nguyen LB; Batta AK; Chen TS; Shefer S
    Hepatology; 1996 Aug; 24(2):440-5. PubMed ID: 8690417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased oxysterol contents in diabetic rat hearts: their involvement in diabetic cardiomyopathy.
    Matsui H; Okumura K; Mukawa H; Hibino M; Toki Y; Ito T
    Can J Cardiol; 1997 Apr; 13(4):373-9. PubMed ID: 9141969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of the cholesterol biosynthetic pathway in osteoblastic differentiation.
    Viccica G; Vignali E; Marcocci C
    J Endocrinol Invest; 2007; 30(6 Suppl):8-12. PubMed ID: 17721067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of dietary oxysterols on coronary arteries in hyperlipidaemic hamsters.
    Meynier A; Lherminier J; Demaison-Meloche J; Ginies C; Grandgirard A; Demaison L
    Br J Nutr; 2002 May; 87(5):447-58. PubMed ID: 12010578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice.
    Ajith TA; Harikumar KB; Thasna H; Sabu MC; Babitha NV
    Clin Chim Acta; 2006 Apr; 366(1-2):322-8. PubMed ID: 16380106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trojan horse-like behavior of a biologically representative mixture of oxysterols.
    Leonarduzzi G; Biasi F; Chiarpotto E; Poli G
    Mol Aspects Med; 2004; 25(1-2):155-67. PubMed ID: 15051324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fast and easy in vitro screening assay for cholesterol biosynthesis inhibitors in the post-squalene pathway.
    Giera M; Plössl F; Bracher F
    Steroids; 2007 Jul; 72(8):633-42. PubMed ID: 17583759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of fatty acid biosynthesis by intermediates of the cholesterol biosynthetic pathway.
    Ku EC
    Biochem Biophys Res Commun; 1996 Aug; 225(1):173-9. PubMed ID: 8769113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Oxysterols: genesis and basic functions].
    Antonchik AV; Zhabinskiĭ VN; Khripach VA
    Bioorg Khim; 2007; 33(3):297-309. PubMed ID: 17682385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The influence of oxidised cholesterol derivatives on morphology of hepatocytes in rat's liver].
    Mazur A; Wiczkowski A; Kubina R
    Wiad Lek; 2011; 64(2):79-83. PubMed ID: 22026270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of oxysterol-like side effects in human monocytic cells treated with phytosterols and oxyphytosterols.
    Vejux A; Montange T; Martine L; Zarrouk A; Riedinger JM; Lizard G
    J Agric Food Chem; 2012 Apr; 60(16):4060-6. PubMed ID: 22490085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholesterol based antineoplastic strategies.
    Lenz M; Miehe WP; Vahrenwald F; Bruchelt G; Schweizer P; Girgert R
    Anticancer Res; 1997; 17(2A):1143-6. PubMed ID: 9137462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of the last two enzymatic reactions in cholesterol biosynthesis in rats: effects of BM 15.766, cholesterol, cholic acid, lovastatin, and their combinations.
    Honda A; Shefer S; Salen G; Xu G; Batta AK; Tint GS; Honda M; Chen TC; Holick MF
    Hepatology; 1996 Aug; 24(2):435-9. PubMed ID: 8690416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular toxicity of oxycholesterols.
    Wielkoszyński T; Gawron K; Strzelczyk J; Bodzek P; Zalewska-Ziob M; Trapp G; Srebniak M; Wiczkowski A
    Bioessays; 2006 Apr; 28(4):387-98. PubMed ID: 16547953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism of new anticancer oxysterol derivatives in rats.
    Moog C; Frank N; Luu B; Bertram B
    Anticancer Res; 1993; 13(4):953-8. PubMed ID: 8352565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological activities of oxysterols.
    Smith LL; Johnson BH
    Free Radic Biol Med; 1989; 7(3):285-332. PubMed ID: 2673947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.